Reproducibility of broth microdilution and comparison to agar dilution for testing CB-183,315 against clinical isolates of Clostridium difficile

Diagnostic Microbiology and Infectious Disease

Volumn 70, Issue 4, 2011, Pages 554-556

  Citron, Diane M ^a   Goldstein, Ellie J C ^a  

^a R M ALDEN RESEARCH LABORATORY   (United States)

Author keywords

Anaerobe; Broth microdilution; CB 183,315; Clostridium difficile; Susceptibility testing

Indexed keywords

CB 183315; MOXIFLOXACIN; POLYPEPTIDE ANTIBIOTIC AGENT; RAZUPENEM; RIFAXIMIN; SULOPENEM; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; GROWTH INHIBITION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; HUMANS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS;

EID: 79960375086     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.04.012     Document Type: Article

References (10)

1. Aldridge K.E., Sanders C.V. Antibiotic- and method-dependant variation in susceptibility testing results of Bacteroides fragilis group isolates. Antimicrob. Agents Chemother. 1987, 25:2317-2321.
2. Baron E.J., Bruckner D.A. Comparison of susceptibilities of anaerobic bacteria determined by agar dilution and a microbroth method. Rev. Inf. Dis 1984, 6(Suppl-1):S249-S253.
3. Citron D.M., Goldstein E.J.C. In vitro activity of CB-183,315 against 542 strains of Clostridium difficile, 446 intestinal anaerobes, and 48 Enterobacteriaceae 2010.
4. Clabots C.R., Johnson S., Bettin K.M., Mathie P.A., Mulligan M.E., Schaberg D.R., Peterson L.R., Gerding D.N. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J. Clin. Microbiol. 1993, 31:1870-1875.
5. Clinical and Laboratory Standards Institute (CLSI) Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria-7th ed. M11-A7 2007, CLSI, Wayne PA.
6. Clinical and Laboratory Standards Institute (CLSI) Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria-7th ed. Informational Supplement. M11-S1 2009, CLSI, Wayne PA.
7. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing; Twenty First Informational Supplement. M100-S21 2011, CLSI, Wayne PA.
8. Goldstein E.J.C., Citron D.M., Goldman P.J., Goldman R.J. National hospital survey of anaerobic culture and susceptibility methods: III. Anaerobe 2008, 14:68-72.
9. Gould C.V., McDonald L.C. Bench-to-bedside review: Clostridium difficile colitis. Crit. Care 2008, 12:203.
10. Hecht D.W., Lederer L., Osmolski J.R. Susceptibility results for the Bacteroides fragilis group: comparison of the broth microdilution and agar dilution methods. Clin. Infect. Dis. 1995, 20(suppl 2):S342-S345.